Followers | 78 |
Posts | 5378 |
Boards Moderated | 0 |
Alias Born | 11/18/2013 |
Monday, November 01, 2021 3:28:49 PM
Recent ABVC News
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 10/25/2024 04:21:35 PM
- ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners • GlobeNewswire Inc. • 10/22/2024 12:45:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2024 09:23:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 08:01:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:30:19 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/16/2024 08:31:34 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/16/2024 08:30:15 PM
- ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements • GlobeNewswire Inc. • 08/15/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:00:31 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 07:18:50 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/07/2024 09:15:18 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/02/2024 04:15:02 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/26/2024 08:30:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 09:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 08:05:34 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 07/12/2024 08:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 12:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:00:15 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/23/2024 08:30:39 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/22/2024 09:00:20 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/22/2024 06:31:18 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/17/2024 09:00:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/17/2024 08:01:51 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 09:00:02 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM